I am back in after reading in the quarterly "and progressed development work to prepare BTX 1801 for a Phase 2 clinical study". I hope this means what I think it means, that BOT will commence Phase II FDA trial this year. I did read that the FDA were expediting trials for any new antibiotics.
This could drop further but it is well into official correction territory now with the share market falling over 10% since last week. 7.5c is a good entry point and any further drops will only be because of further panic in the market which is an unknown.
Ann: Half Yearly Report and Accounts, page-20
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.010(3.70%) |
Mkt cap ! $421.3M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.0¢ | $800.8K | 2.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 1212545 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 360578 | 8 |
View Market Depth
| Last trade - 14.33pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.3¢ |
Change
-0.010 ( 2.09 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.5¢ | 26.0¢ | 2150045 | ||
| Last updated 14.46pm 15/05/2024 ? | |||||
| BOT (ASX) Chart |